Nuralogix Corporation
Explore this company’s associated devices, FDA decisions and regulatory history.

Nuralogix Corporation
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Nuralogix Corporation. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jun 11, 2026 to Jun 11, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QME appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 250 University Ave., Suite 209, Toronto, M5H3E5, CA. Recorded on K253650, decision dated Jun 11, 2026.
Device categories in this collection
Software For Optical Camera-Based Measurement Of Pulse Rate, Heart Rate, Breathing Rate, And/Or Respiratory Rate.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
Anura Mobile Core SDK (M1)
K253650 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.